Recent methods for diagnosis of diabetes mellitus
Abstract
The diagnostic criteria for Diabetes mellitus have been modified from those previously recommended by the NDDG or WHO. Three ways to diagnose Diabetes are possible, and each must be confirmed, on a subsequent day, by any one of the three methods. For example, one instance of symptoms with casual plasma glucose >200 mg/dl (11.1 mmol/l), confirmed on a subsequent day by 1)^PG >126 mg/dl (7.0 mmol/l), 2) an OGTT with the 2- h postload value >200 mg/dl (11.1 mmol/l), or 3) symptoms with a casual plasma glucose >200 mg/dl (11.1 mmol/l), warrants the diagnosis of Diabetes.For epidemiological studies, estimates of Diabetes prevalence and incidence should be based on an FPG >126 mg/dl (7.0 mmol/l). This recommendation has been made in the interest of standardization and also to facilitate field-work, particularly where the OGTT may be difficult to perform and where the cost and demands on participants' time may be excessive.
References
2. American Diabetes Association, “Standards of medical care in diabetes”, Diabetes Care, 2010; 33(1):S11-S61, 2010.
3. Adachi T., Ohta H., Yamada H., Futenma A., Kato K., Hirano K., Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Elsevier, 2007; 212(3):11-28.
4. Halkjaer J., Thorkild S., Anne J. T., Togoper CH, Berit HL., Food and Drinking Patterns as Predictors of 6 Year BMI- Adjusted Changes In Waist Circumstance, British Journal of Nutrition, 2004; 92:735-748.
5. Belay A., Kato T., Ota Y., Spirulina (Arthrospira): Potential Application as an Animal Feed Supplement, J Appl Phycol, 1996; 8:303-311.
6. Belay A., Ota Y., Miyakawa K., Shimamatsu H., Production of High Quality Spirulina at Earthrise Farms. In: Phang SM, editor. Algal Biotechnology in the Asia Pacific Region, Kuala Lumpur: University of Malaya, 1994, Pp. 92-102.
7. Janka H.V. and Michaelis D., Epidemiology Of Diabetes Mellitus, Prevalene, Incidence, Pathogenesis And Prognosis, German Article, 2003; 96(3):159-165.
8. Jannette C., Brand M., Susanna H. A., Holt D. B., Pawlak and Mcmillan., Glycemic Index And Obesity, American Journal Of Clinical Nutrition, 2002; 28(IS- 5S):510.
9. Abate N and Manisha C., Ethnicity and Type 2 Diabetes-Focus on Asian Indians, Journal of Diabetes and it’s Complications, 2001; 15:320-327.
10. Campanella L., Elizabetta M., Rita, G., Manuro T., Antioxidant Capacity of Dry Vegetal Extracts Checked by Voltammetric Method, Journal of Food, Agriculture And Environment, 2006; 4:54-56
11. Adams C. A., Nutricines: Food components in Health and Nutrition, Nottingham University Press, Nottingham, 1999, Pp. 16-17.
12. Adèr H. J., Mellenbergh G. J and Hand, D. J., Advising on research methods: A consultant's companion, The Netherlands: Johannes van Kessel Publishing, Netherland, 2008, Pp. 273-278.
13. Canadian Diabetes Association, Guidelines For The Nutritional Management Of Diabetes Mellitus In The New Millennium: A Position Statement By The Canadian Diabetes Association, Canadian Journal of Diabetes Care, 2000; 23:56-69.
14. Dambal S.S., Indumati V., Suchetha Kumari.. Role of Oxidative Stress in Obesity with an Insight into Type Il Diabetes Mellitus, Journal of Clinical and Diagnostic Research, 2011; 5:52-54.
15. Dan Lukaczer N.D., Liska J., DeAnn D., Robert H. L. and Jeffery, S. B., Effect of a Low Glycemic Index Diet with Soy Protein and Phytosterols on CVD Risk Factors in Post Menopausal Women, Nutrition, 2006; 22(2):104-113.
16. Drummound E. K., The Customer Check on the Experts, J Am Dietetic Assoc. 1953; 29:552
17. Easwaran P. P., Vidhya, K., Alamelu, M. S., Vasanthamani, G., Impact of Antioxidant Vitamins E and C on the Lipid Profile of Hyperlipidemics, The Indian Journal of Nutrition and Dietetics, 2002, Vol: 39, p. 1.
18. Friedemann TE, Sheft BB, Miller VC, “An assessment of the value of nitroprusside reaction for the determination of ketone bodies in urine” Queens Bullettin of Northwestern University Medical School, 1946; 20:301-310
The International Journal of Innovative Science & Technology affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJIST.
Download link for COPYRIGHT FORM
